Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial
Crossref DOI link: https://doi.org/10.1186/s12895-016-0051-4
Published Online: 2016-10-03
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Papp, Kim A.
Bissonnette, Robert
Gooderham, Melinda
Feldman, Steven R.
Iversen, Lars
Soung, Jennifer
Draelos, Zoe
Mamolo, Carla
Purohit, Vivek
Wang, Cunshan
Ports, William C.
Funding for this research was provided by:
Pfizer
License valid from 2016-10-03